Indication
Reversal of neuromuscular blockade induced by rocuronium or vecuronium. For the peadiatric population: sugammadex is only recommended for routine reversal of rocuronium-induced blockade in children and adolescents.
Loading your page…
Loading your page…
Neuromuscular Blockade
Marketing Authorisation Holder: Merck Sharp & Dohme B.V.
EMA Authorisation: 25/07/2008
INN: sugammadex
AI Drug & Interaction Analysis
Free account required
Ask Osler about Bridion: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.